Navigation Links
Novavax Announces New Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call
Date:3/26/2009

Statements

Statements herein relating to future development results and performance, conditions or strategies and other matters, including expectations regarding product and clinical developments, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks relating to the early stage of Novavax's product candidates under development; current results may not be predictive of future pandemic results, results of our seasonal influenza vaccine or any other vaccine that we may develop; further testing is required before regulatory approval can be applied for and the FDA may not approve a vaccine even if further trial results are similar to those disclosed previously by the company; uncertainties relating to clinical trials, including possible delays in initiating or completing the trials and safety and efficacy results; dependence on the efforts of third parties; competition for clinical resources and patient enrollment from drug candidates in development by other companies with greater resources and visibility; and risks that we may lack the financial resources and access to capital to fund our operations including further clinical trials. Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at http://www.sec.gov. These forward-looking statements speak only as of the date of this press release, and Novavax assumes no duty to update forward-looking statements.


'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call
2. Novavax to Present at Cowen and Company 29th Annual Healthcare Conference
3. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
4. Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines
5. Novavax Announces Operational Status of Its Vaccine Pilot Plant and Commercial Launch Facility
6. Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009
7. NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate
8. Novavax to Present Seasonal Influenza Data Results in an Investor Conference Call on December 11, 2008
9. Novavax CEO to Present at Piper Jaffray 20th Annual Healthcare Conference
10. Novavax CEO to Present at Lazard Capital Markets 5th Annual Healthcare Conference
11. Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... (PRWEB) March 26, 2015 "In America," the ... the United States that is hosted by legendary film actor ... topic of botany in an upcoming segment. , Botany ... in reality it is actually quite a bit more complicated ... of different types of living organisms, from the smallest bacteria ...
(Date:3/26/2015)... WriteResult, a premier provider of ePRO technologies ... School of Public Health and New Haven Farms to ... month-long project. The goal of the study was to ... free access to fresh produce and nutrition education on ... high blood pressure, diabetes and weight gain. Patients completed ...
(Date:3/25/2015)... Balaton, MN (PRWEB) March 26, 2015 ... an upcoming episode of American Farmer, airing for the ... RFD-TV. The segment of American Farmer will explore the ... Agnition provides crop producers with a patented Microbial Catalyst™ ... farms and greater yields. The segment will air again ...
(Date:3/25/2015)... -- Optimal Research, LLC has been nominated as a ... Clinical Site or Trial Network". This is ... as a nominee in this ViE award category at ... in 2014. The ViE awards were created to honor ... contributions of companies and individuals in the vaccine industry. ...
Breaking Biology Technology:Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 2Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2Optimal Research Nominated 2015 Vaccine Industry Excellence (ViE) Award 2
... Aug. 20 Inc. magazine announced,its 27th annual Inc. ... Federal Information Technology (IT) services provider,MicroTech, ranks No. 285 ... The 2008 Inc. 500 list measures revenue growth from ... privately held, independent -,no subsidiaries or divisions of other ...
... MINNEAPOLIS, Aug. 20 Medication Management Systems,(MMS) ... North Dakota Pharmacy,Service Corporation -- the result ... therapy management (MTM) health benefit for North,Dakota ... diabetes. The MMS,Assurance Pharmaceutical Care System(TM) will ...
... Six Months Profit Resulting From Enhanced ... Operations and New Agreements, ... ISCR), a leading distributor of at-home testing diagnostics,for the chronically ... e-health and EMR applications, reported,financial results for the second quarter ...
Cached Biology Technology:MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes 2InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 2InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 3InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 4InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 5InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 6
(Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
(Date:3/20/2015)... Mar. 19, 2015 Research and Markets ( ... Biometrics - Global Strategic Business Report" report to their ... Iris Biometrics in US$ Thousands. The report provides separate comprehensive ... Japan , Europe , ... and Latin America . Annual ...
(Date:3/17/2015)... NEW YORK , March 17, 2015 /PRNewswire/ ... , the largest exhibition for service robots ever ... . RoboUniverse takes place on May 11-13, 2015 ... Sponsors and exhibitors for the event include: Acorn ... Motion Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... A single, oral dose of vitamin A, given to infants shortly ... death by 15 percent, according to a study conducted by researchers ... is published in the July 2008 edition of the journal ... supplementation can reduce mortality in children over 6 months of age. ...
... number of tumor cells circulating in the bloodstream of ... well they are responding to treatment, new results show. ... the European Society for Medical Oncology, researchers showed that ... the outcome after chemotherapy in this hard to treat ...
... would seem a healthier place for toads than a ditch ... scientists have found the opposite is true. In a study ... chemicals pose a threat to amphibians, UF zoologists have found ... from reproductive system abnormalities than toads near farms where ...
Cached Biology News:Newborn vitamin A reduces infant mortality 2New study points to agriculture in frog sexual abnormalities 2New study points to agriculture in frog sexual abnormalities 3
... This benchtop ductless exhaust hood ventilates ... safe indoor release of exhaust. Bonded ... Over 28" of vertical clearance (with ... Includes polypropylene spill tray; options include ...
... These versatile enclosures are ... nitrogen or other process ... low-humidity environment. HEPA filtration, ... ionization modules also available, ...
... For the professional, student, or faculty researcher, the ... accelerate your research and improve the quality of ... is the edge that researchers using LI-COR DNA ... years. The 4300 System is a third generation ...
... isolation chamber provides a safe, clean ... pharmaceuticals, in accord with USP-797 requirements. ... (ISO 5) cleanliness conditions in the ... rod and tilt-up front panel for ...
Biology Products: